Table of Contents

1 Study Coverage

• 1.1 Famciclovir Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Famciclovir Market Size Growth Rate by Product
  • 1.4.2 125 mg Tablets
  • 1.4.3 250 mg Tablets
  • 1.4.4 500 mg Tablets
• 1.5 Market by End User
  • 1.5.1 Global Famciclovir Market Size Growth Rate by End User
  • 1.5.2 Cold sores
  • 1.5.3 Genital herpes
  • 1.5.4 Shingles
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Famciclovir Market Size
  • 2.1.1 Global Famciclovir Revenue 2014-2025
  • 2.1.2 Global Famciclovir Sales 2014-2025
• 2.2 Famciclovir Growth Rate by Regions
  • 2.2.1 Global Famciclovir Sales by Regions
  • 2.2.2 Global Famciclovir Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Famciclovir Sales by Manufacturers
  • 3.1.1 Famciclovir Sales by Manufacturers
  • 3.1.2 Famciclovir Sales Market Share by Manufacturers
  • 3.1.3 Global Famciclovir Market Concentration Ratio (CR5 and HHI)
• 3.2 Famciclovir Revenue by Manufacturers
  • 3.2.1 Famciclovir Revenue by Manufacturers (2014-2019)
  • 3.2.2 Famciclovir Revenue Share by Manufacturers (2014-2019)
• 3.3 Famciclovir Price by Manufacturers
• 3.4 Famciclovir Manufacturing Base Distribution, Product Types
  • 3.4.1 Famciclovir Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Famciclovir Product Type
  • 3.4.3 Date of International Manufacturers Enter into Famciclovir Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Famciclovir Sales by Product
• 4.2 Global Famciclovir Revenue by Product
• 4.3 Famciclovir Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Famciclovir Breakdown Data by End User

6 North America

• 6.1 North America Famciclovir by Countries
  • 6.1.1 North America Famciclovir Sales by Countries
  • 6.1.2 North America Famciclovir Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Famciclovir by Product
• 6.3 North America Famciclovir by End User

7 Europe

• 7.1 Europe Famciclovir by Countries
  • 7.1.1 Europe Famciclovir Sales by Countries
  • 7.1.2 Europe Famciclovir Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Famciclovir by Product
• 7.3 Europe Famciclovir by End User

8 Asia Pacific

• 8.1 Asia Pacific Famciclovir by Countries
  • 8.1.1 Asia Pacific Famciclovir Sales by Countries
  • 8.1.2 Asia Pacific Famciclovir Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Famciclovir by Product
• 8.3 Asia Pacific Famciclovir by End User

9 Central & South America

• 9.1 Central & South America Famciclovir by Countries
  • 9.1.1 Central & South America Famciclovir Sales by Countries
  • 9.1.2 Central & South America Famciclovir Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Famciclovir by Product
• 9.3 Central & South America Famciclovir by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Famciclovir by Countries
  • 10.1.1 Middle East and Africa Famciclovir Sales by Countries
  • 10.1.2 Middle East and Africa Famciclovir Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Famciclovir by Product
• 10.3 Middle East and Africa Famciclovir by End User

11 Company Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novartis Famciclovir Products Offered
  • 11.1.5 Novartis Recent Development
• 11.2 Mylan
  • 11.2.1 Mylan Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Mylan Famciclovir Products Offered
  • 11.2.5 Mylan Recent Development
• 11.3 Teva
  • 11.3.1 Teva Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Teva Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Teva Famciclovir Products Offered
  • 11.3.5 Teva Recent Development
• 11.4 Cipla
  • 11.4.1 Cipla Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Cipla Famciclovir Products Offered
  • 11.4.5 Cipla Recent Development
• 11.5 Hikma
  • 11.5.1 Hikma Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Hikma Famciclovir Products Offered
  • 11.5.5 Hikma Recent Development
• 11.6 Apotex
  • 11.6.1 Apotex Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Apotex Famciclovir Products Offered
  • 11.6.5 Apotex Recent Development
• 11.7 Aurobindo Pharma
  • 11.7.1 Aurobindo Pharma Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Aurobindo Pharma Famciclovir Products Offered
  • 11.7.5 Aurobindo Pharma Recent Development
• 11.8 Macleods Pharmaceuticals
  • 11.8.1 Macleods Pharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Macleods Pharmaceuticals Famciclovir Products Offered
  • 11.8.5 Macleods Pharmaceuticals Recent Development
• 11.9 Beijing Jialin Pharmaceutical
  • 11.9.1 Beijing Jialin Pharmaceutical Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Beijing Jialin Pharmaceutical Famciclovir Products Offered
  • 11.9.5 Beijing Jialin Pharmaceutical Recent Development
• 11.10 HETERO
  • 11.10.1 HETERO Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 HETERO Famciclovir Products Offered
  • 11.10.5 HETERO Recent Development
• 11.11 Hainan choitec Pharmaceuticals
• 11.12 Shandong Luoxin Pharmaceutical Group
• 11.13 Chengdu Diao Pharmaceutical Group
• 11.14 HISUN

12 Future Forecast

• 12.1 Famciclovir Market Forecast by Regions
  • 12.1.1 Global Famciclovir Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Famciclovir Revenue Forecast by Regions 2019-2025
• 12.2 Famciclovir Market Forecast by Product
  • 12.2.1 Global Famciclovir Sales Forecast by Product 2019-2025
  • 12.2.2 Global Famciclovir Revenue Forecast by Product 2019-2025
• 12.3 Famciclovir Market Forecast by End User
• 12.4 North America Famciclovir Forecast
• 12.5 Europe Famciclovir Forecast
• 12.6 Asia Pacific Famciclovir Forecast
• 12.7 Central & South America Famciclovir Forecast
• 12.8 Middle East and Africa Famciclovir Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Famciclovir Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
The global Famciclovir market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Famciclovir market based on company, product type, end user and key regions.

This report studies the global market size of Famciclovir in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Famciclovir in these regions.
This research report categorizes the global Famciclovir market by top players/brands, region, type and end user. This report also studies the global Famciclovir market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN

Market size by Product
125 mg Tablets
250 mg Tablets
500 mg Tablets
Market size by End User
Cold sores
Genital herpes
Shingles

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Famciclovir market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Famciclovir market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Famciclovir companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Famciclovir submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Famciclovir are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Famciclovir market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.